Variable effects of underlying diseases on the prognosis of patients with COVID-19
Adult
Adolescent
Science
610
Comorbidity
Mortality / trends
Pulmonary Disease
Pulmonary Disease, Chronic Obstructive
03 medical and health sciences
0302 clinical medicine
Neoplasms
Chronic Obstructive / epidemiology*
80 and over
Diabetes Mellitus
Humans
Mortality
Preschool
Child
COVID-19 / epidemiology*
Aged
Aged, 80 and over
Heart Failure
Kidney Diseases / epidemiology*
Q
Diabetes Mellitus / epidemiology*
Length of Stay / statistics & numerical data
R
COVID-19
Infant
Length of Stay
Middle Aged
Survival Analysis
3. Good health
COVID-19 / mortality
Heart Failure / epidemiology*
Child, Preschool
Medicine
Kidney Diseases
Neoplasms / epidemiology*
Research Article
DOI:
10.1371/journal.pone.0254258
Publication Date:
2021-07-19T17:36:50Z
AUTHORS (9)
ABSTRACT
Underlying diseases might be risk factors for poor prognosis in patients with coronavirus disease (COVID-19); however, we still do not know whether these are independent affecting prognosis, which type of underlying factors, and clinical outcomes affected. We retrospectively reviewed cohort data from 7,590 de-identified COVID-19 who were diagnosed using severe acute respiratory syndrome-coronavirus-2 RNA polymerase chain reaction test up to May 15, 2020. used linked-medical claims provided by the Health Insurance Review Assessment Service South Korea. identified diagnostic codes patients’ files January 1, 2019 December 31, 2019. The total mortality rate was 3.0% COVID-19. After adjusting age, sex, concomitant chronic conditions, found that congestive heart failure, pulmonary diseases, diabetes without complications, renal malignancy significantly increased cost treatment. Cerebrovascular disease, paralysis significant prolonging hospital stay. Diabetes complications independently associated intensive care unit admission. In addition, failure (odds ratio [OR], 1.724; P = 0.003), dementia (OR, 1.598; 0.012), 1.821; 0.002 OR, 1.518; 0.022, respectively), 2.299; 0.002), 1.529; 0.039) death, even after adjustments. effects variable according outcome. Therefore, should monitored more closely because they at a prognosis.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (35)
CITATIONS (28)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....